Is LNSR or PMN more profitable?

LNSR runs the higher net margin — LNSR at 57.57% versus PMN at 0.00%.

How have LNSR and PMN total returns compared?

Over the past 5 years, LNSR delivered -3.18% and PMN delivered -47.05% annualized total return. Past performance doesn't predict future results.

LENSAR Inc (LNSR) vs ProMIS Neurosciences, Inc. (PMN)

A side-by-side comparison of LENSAR Inc and ProMIS Neurosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LNSR

LENSAR Inc

$83M

$6.74HealthcareDelayed quote: Oct 6, 2026, 12:17 PM EDT

PMN

ProMIS Neurosciences, Inc.

$85M

$9.43HealthcareDelayed quote: Oct 6, 2026, 12:13 PM EDT

Total return — LNSR vs PMN

growth of $100 · dividends reinvested · last 6y

LNSR -25.9% (-4.9%/yr)PMN -94.3% (-38.0%/yr)LNSR compounded faster over this window

Log scale — wide-divergence pair

LNSR PMN

LNSR vs PMN: by the numbers

•PMN is the larger company ($85M vs $83M market cap).
•LNSR is profitable (57.57% net margin) while PMN runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	LNSR	PMN
P/S ratio	1.37	N/A
P/B ratio	5.55	1.71

Profitability

Metric	LNSR	PMN
Gross margin	47.96%	0.00%
Operating margin	-42.06%	0.00%
Net margin	57.57%	0.00%
ROE	232.78%	-85.48%
ROIC	-16.28%	-87.79%

Growth (annualized)

Metric	LNSR	PMN
Revenue CAGR (5Y)	14.67%	N/A
Total return CAGR (5Y)	-3.18%	-47.05%

Frequently asked

Is LNSR or PMN more profitable?: LNSR runs the higher net margin — LNSR at 57.57% versus PMN at 0.00%.
How have LNSR and PMN total returns compared?: Over the past 5 years, LNSR delivered -3.18% and PMN delivered -47.05% annualized total return. Past performance doesn't predict future results.

Go deeper

Full LNSR analysis Full PMN analysis Interactive comparison tool

Dig into the metrics

LENSAR ROE ProMIS Neurosciences ROE LENSAR operating margin ProMIS Neurosciences operating margin LENSAR revenue growth ProMIS Neurosciences revenue growth LENSAR free cash flow ProMIS Neurosciences free cash flow

LENSAR & ProMIS Neurosciences appear in these rankings

Highest ROE Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.